0000950170-24-076379.txt : 20240621
0000950170-24-076379.hdr.sgml : 20240621
20240621175955
ACCESSION NUMBER: 0000950170-24-076379
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240620
FILED AS OF DATE: 20240621
DATE AS OF CHANGE: 20240621
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Polsky Bruce
CENTRAL INDEX KEY: 0001508458
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39661
FILM NUMBER: 241061587
MAIL ADDRESS:
STREET 1: C/O VISION-SCIENCES, INC.
STREET 2: 40 RAMLAND ROAD
CITY: ORANGEBURG
STATE: NY
ZIP: 10962
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Atea Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001593899
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 460574869
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 225 FRANKLIN STREET
STREET 2: SUITE 2100
CITY: BOSTON
STATE: MA
ZIP: 02110
BUSINESS PHONE: 857-204-8109
MAIL ADDRESS:
STREET 1: 225 FRANKLIN STREET
STREET 2: SUITE 2100
CITY: BOSTON
STATE: MA
ZIP: 02110
4
1
ownership.xml
4
X0508
4
2024-06-20
0001593899
Atea Pharmaceuticals, Inc.
AVIR
0001508458
Polsky Bruce
225 FRANKLIN STREET
SUITE 2100
BOSTON
MA
02110
true
false
false
false
false
Common Stock
2024-06-20
4
S
false
17544
3.4852
D
65606
D
Restricted Stock Units
2024-06-21
4
A
false
29600
0.00
A
Common Stock
29600
29600
D
Stock Option (Right to Buy)
3.44
2024-06-21
4
A
false
41200
0.00
A
2034-06-20
Common Stock
41200
41200
D
The shares were sold solely to cover taxes upon the vesting of restricted stock units. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.43 to $3.53, inclusive.
Restricted stock units convert into common stock on a one-for-one basis.
The restricted stock units vest in a single installment on the earlier of (i) the date of the next annual meeting of the Issuer's stockholders occurring after the date of grant or (ii) the first anniversary of the date of grant, in each case, subject to the Reporting Person's continued service through the applicable vesting date.
The option vests and becomes exercisable in twelve (12) substantially equal monthly installments following June 21, 2024, such that the option shall be fully vested on the first anniversary of the date of grant, subject to the Reporting Person's continued service through each such vesting date.
/s/ Andrea Corcoran, as Attorney-in-Fact for Bruce Polsky
2024-06-21